ST. LOUIS, April 26, 2018 -- Stifel Financial Corp. (NYSE:SF) today announced that Stephen Gengaro has joined the firm as Managing Director and Senior Analyst covering the oilfield services sector. Mr. Gengaro will be based in Stifel’s Florham Park, New Jersey, office.
“As crude prices rise, companies that provide services and equipment to the oilfield sector are very much in focus for investors,” said Keith Gay, Director of Research at Stifel. “We are pleased to have someone of Stephen’s caliber join our growing energy team at this crucial time for the industry.”
Mr. Gengaro comes to Stifel after covering oilfield service and equipment stocks for more than 20 years at firms including ING/Furman Selz, ABN AMRO, Jefferies, and Sterne Agee/CRT. Most recently he worked at Loop Capital, covering the sector as part of the company’s startup effort in equity research. Stephen received his B.A. from Catholic University and his M.B.A. from Boston College.
This addition greatly enhances Stifel’s presence in the energy & power sector. Stephen Gengaro joins fellow analysts Selman Akyol, Robin Haworth, Mike Scialla, and Derrick Whitfield, who together will cover approximately 130 companies within the U.S. and European energy infrastructure, oil and gas exploration and production, and oilfield services areas.
Outstanding research is just one way Stifel supports the institutional market in energy. Other ways Stifel supports clients operating in or investing in the energy sector include:
- An investment banking team, recently fortified by new Houston-based hire Jay Levy, who joined from Jefferies, offering a variety of services to corporate clients
- Market making in more than 230 energy-specific stocks, ranking Stifel among the 20 largest traders of energy stocks
- Dedicated equity sales specialist
- Fixed income coverage of more than 150 energy-related companies
Stifel Company Information
Stifel Financial Corp. (NYSE:SF) is a financial services holding company headquartered in St. Louis, Missouri, that conducts its banking, securities, and financial services business through several wholly owned subsidiaries. Stifel’s broker-dealer clients are served in the United States through Stifel, Nicolaus & Company, Incorporated; Keefe Bruyette & Woods, Inc.; Miller Buckfire & Co., LLC; and Century Securities Associates, Inc., and in the United Kingdom and Europe through Stifel Nicolaus Europe Limited. The Company’s broker-dealer affiliates provide securities brokerage, investment banking, trading, investment advisory, and related financial services to individual investors, professional money managers, businesses, and municipalities. Stifel Bank & Trust offers a full range of consumer and commercial lending solutions. Stifel Trust Company, N.A. and Stifel Trust Company Delaware, N.A. offer trust and related services. To learn more about Stifel, please visit the Company’s website at www.stifel.com.
Media Contact
Neil Shapiro, (212) 271-3447
[email protected]
Investor Relations Contact
Joel Jeffrey, (212) 271-3610
[email protected]


J.P. Morgan Upgrades Diploma, Lifts Price Target to 8,250p
OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing
Google Expands Gemini Enterprise With AI Tools for Legal Sector
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake
Bathla Group Hires Administrators as Australia Housing Slump Deepens
Xiaomi Unveils Xring O3 Chip for Flagship Foldable Phone
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook
SEC Probes Banks Over Situational Awareness Hedge Fund Collapse
Meta, U.S. States Discuss Settlement in Teen Addiction Trial
Australia’s Big Four Banks Face Mortgage Slowdown as Valuations Draw Scrutiny
SK Hynix Shares Fall as Workers Reject Wage Deal
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat
Luxshare Shares Rise as First-Half Profit Jumps 18%
Woodside Drops $5 Billion Clean Energy Plan as Profit Rises 7%
Yindjibarndi Appeals Fortescue Mining Compensation Ruling
Trump Administration Plans New Drug Pricing Deals With Biotech Firms 



